Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Arnaud A. Mailleux"'
Autor:
Sara Cuevas Ocaña, Natalia El-Merhie, Merian E. Kuipers, Mareike Lehmann, Sara Rolandsson Enes, Carola Voss, Lareb S.N. Dean, Matthew Loxham, Agnes W. Boots, Suzanne M. Cloonan, Catherine M. Greene, Irene H. Heijink, Audrey Joannes, Arnaud A. Mailleux, Nahal Mansouri, Niki L. Reynaert, Anne M. van der Does, Darcy E. Wagner, Niki Ubags
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
In this review, the Basic and Translational Science Assembly of the European Respiratory Society provides an overview of the 2022 International Congress highlights. We discuss the consequences of respiratory events from birth until old age regarding
Externí odkaz:
https://doaj.org/article/0f55052858ca47dfa7980cee3f5d1a8d
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 324:L737-L746
Idiopathic pulmonary fibrosis (IPF) is a rare interstitial lung disease with a poor prognosis. Chronic microinjuries, mainly caused by environmental factors to an aging alveolar epithelium, would lead to the aberrant differentiation and accumulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2507f04c8307243c73cc37a426b7fc7b
https://doi.org/10.1152/ajplung.00229.2022
https://doi.org/10.1152/ajplung.00229.2022
Autor:
Mada Ghanem, Arnaud A. Mailleux
Publikováno v:
Am J Respir Cell Mol Biol
We previously identified a novel molecular subtype of idiopathic pulmonary fibrosis (IPF) defined by increased expression of cilium-associated genes, airway mucin gene MUC5B, and KRT5 marker of basal cell airway progenitors. Here we show the associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0afdb235a217c2b1a3589305d504043
https://doi.org/10.1165/rcmb.2022-0201ed
https://doi.org/10.1165/rcmb.2022-0201ed
Autor:
Arnaud A. Mailleux, Bruno Crestani
Publikováno v:
European Respiratory Journal. 60:2201536
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6452a5cfdf75eb37b9643e9196504477
https://doi.org/10.1183/13993003.01536-2022
https://doi.org/10.1183/13993003.01536-2022
Autor:
Natacha, Cigna, Elika, Farrokhi Moshai, Stéphanie, Brayer, Joëlle, Marchal-Somme, Lidwine, Wémeau-Stervinou, Aurélie, Fabre, Hervé, Mal, Guy, Lesèche, Monique, Dehoux, Paul, Soler, Bruno, Crestani, Arnaud A, Mailleux
Publikováno v:
The American journal of pathology. 181(6)
Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown cause. Key signaling developmental pathways are aberrantly expressed in IPF. The hedgehog pathway plays a key role during fetal lung development and may be involved in lung fibro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a35b818b605c4d7ddeec64db0addd946
https://pubmed.ncbi.nlm.nih.gov/23031257
https://pubmed.ncbi.nlm.nih.gov/23031257
Autor:
Emmeline Marchal-Duval, Méline Homps-Legrand, Antoine Froidure, Madeleine Jaillet, Mada Ghanem, Deneuville Lou, Aurélien Justet, Arnaud Maurac, Aurelie Vadel, Emilie Fortas, Aurelie Cazes, Audrey Joannes, Laura Giersh, Herve Mal, Pierre Mordant, Tristan Piolot, Marin Truchin, Carine M Mounier, Ksenija Schirduan, Martina Korfei, Andreas Gunther, Bernard Mari, Frank Jaschinski, Bruno Crestani, Arnaud A Mailleux
Publikováno v:
eLife, Vol 12 (2023)
Matrix remodeling is a salient feature of idiopathic pulmonary fibrosis (IPF). Targeting cells driving matrix remodeling could be a promising avenue for IPF treatment. Analysis of transcriptomic database identified the mesenchymal transcription facto
Externí odkaz:
https://doaj.org/article/def471563ad64a989723cceb324f9f6d
Autor:
Ghanem M; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Justet A; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Jaillet M; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Vasarmidi E; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Boghanim T; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Hachem M; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Vadel A; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Joannes A; INSERM U1085, IRSET Institut de Recherche sur la Santé, l'Environnement et le Travail, Université de Rennes-1, Rennes, France., Mordant P; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Chirurgie Thoracique et vasculaire, Paris, France., Balayev A; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Adams T; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, United States., Mal H; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie et Transplantation, Paris, France., Cazes A; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Assistance Publique des Hôpitaux de Paris, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Poté N; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Assistance Publique des Hôpitaux de Paris, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Mailleux A; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France., Crestani B; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale, UMR1152, FHU APOLLO, Labex INFLAMEX, Faculté de médecine Xavier Bichat, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie A, Centre de Référence des Maladies Pulmonaires Rares, Paris, France.
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2024 Dec 01; Vol. 327 (6), pp. L818-L830. Date of Electronic Publication: 2024 Oct 01.
Autor:
Reddy KD; Epigenetics of Chronic Lung Disease Group, Forschungszentrum Borstel Leibniz Lungenzentrum, Borstel, Germany.; Division of Pediatric Pneumology and Allergology, University Medical Center Schleswig-Holstein, Lübeck, Germany.; These authors contributed equally., Bizymi N; Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece.; These authors contributed equally., Schweikert A; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; These authors contributed equally., Ananth S; London North West University Healthcare NHS Trust, London, UK.; These authors contributed equally., Lim CX; Institute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Lung Health, Clinic Penzing, Vienna, Austria.; These authors contributed equally., Lodge KM; National Heart and Lung Institute, Imperial College London, London, UK.; These authors contributed equally., Joannes A; Université de Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France., Ubags N; Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland., van der Does AM; PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands., Cloonan SM; School of Medicine, Trinity Biosciences Institute, Trinity College Dublin, Dublin, Ireland., Mailleux A; Université Paris Cité, Inserm, Physiopathologie et épidémiologie des maladies respiratoires, Paris, France., Mansouri N; Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland., Reynaert NL; Department of Respiratory Medicine and School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands., Heijink IH; University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands., Cuevas-Ocaña S; Biodiscovery Institute, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Publikováno v:
ERJ open research [ERJ Open Res] 2024 Apr 29; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024).
Autor:
Koether K; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Besnard V; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France., Sandig H; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Carruthers A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Miranda E; Imaging and AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Grootenboer-Mignot S; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Taillé C; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France., Chevret S; Biostatistics and Clinical Epidemiology team, INSERM UMR 1153, Université de Paris, SBIM- Hôpital Saint Louis, Paris, France., Valeyre D; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Nunes H; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Israel-Biet D; AP-HP, Hôpital Européen Georges Pompidou, Service de Pneumologie, Université de Paris, Paris, France., Lim WK; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Cottin V; Hospices Civils de Lyon, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France., Corkill D; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dobson C; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Groves M; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Ferraro F; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Guenzi E; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Huang L; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sulikowski M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mailleux A; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Murray LA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mustelin T; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA., Strickland I; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Sleeman MA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Crestani B; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France bruno.crestani@aphp.fr.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.
Publikováno v:
The European respiratory journal [Eur Respir J] 2023 May 18; Vol. 61 (5). Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Autor:
Garnier M; Service D'anesthésie-Réanimation et Médecine Périopératoire - Rive Droite, Sorbonne Université, GRC 29, DMU DREAM, Site Tenon, 4 rue de la Chine, Paris 75020, France; INSERM UMR 1152 Physiopathologie et Épidémiologie des Maladies Respiratoires, Université Paris Cité, Site Bichat, 16 rue Henri Huchard, Paris 75018, France. Electronic address: marc.garnier@aphp.fr., Blanchard F; INSERM UMR 1152 Physiopathologie et Épidémiologie des Maladies Respiratoires, Université Paris Cité, Site Bichat, 16 rue Henri Huchard, Paris 75018, France; Service D'anesthésie-Réanimation et Médecine Périopératoire, Hôpital de la Pitié Salpêtrière, Sorbonne Université, GRC 29, DMU DREAM, 47-83 boulevard de l'hôpital, Paris 75013, France., Mailleux A; INSERM UMR 1152 Physiopathologie et Épidémiologie des Maladies Respiratoires, Université Paris Cité, Site Bichat, 16 rue Henri Huchard, Paris 75018, France., Morand-Joubert L; Département de Virologie, Hôpitaux Universitaire St Antoine - Tenon - Trousseau, Assistance Publique - Hôpitaux de Paris, Paris, France; INSERM UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université, Paris, France., Crestani B; INSERM UMR 1152 Physiopathologie et Épidémiologie des Maladies Respiratoires, Université Paris Cité, Site Bichat, 16 rue Henri Huchard, Paris 75018, France; Université Paris Cité, DMU VICTOIRE, Service de Pneumologie A, Hôpital Bichat, 46 rue Henri Huchard, Paris 75018, France., Quesnel C; Service D'anesthésie-Réanimation et Médecine Périopératoire - Rive Droite, Sorbonne Université, GRC 29, DMU DREAM, Site Tenon, 4 rue de la Chine, Paris 75020, France; INSERM UMR 1152 Physiopathologie et Épidémiologie des Maladies Respiratoires, Université Paris Cité, Site Bichat, 16 rue Henri Huchard, Paris 75018, France.
Publikováno v:
Immunology letters [Immunol Lett] 2022 Nov 13; Vol. 251-252, pp. 107-112. Date of Electronic Publication: 2022 Nov 13.